Dr Reddy's eyes 'transformative' gains from differentiated assets
This article was originally published in Scrip
Executive Summary
More details on Dr Reddy's Laboratories' proprietary products business have emerged, with the firm disclosing that it has more than half a dozen programs in the pipeline in the dermatology and neurology space each, including early stage ones for non-genital warts, actinic keratosis (AK) and Parkinson's.